Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 5, 2009, Pages 543-549

  Servais, Geneviève ^a,b   Karmali, Rafik ^a   Guillaume, Marie Paule ^a   Badot, Valérie ^a   Duchateau, Jean ^a   Corazza, Francis ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anti DNA; Antinuclear antibodies; Auto antibodies; HEp2; SLE

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS DNA; DNA ANTIBODY; DOUBLE STRANDED DNA;

ALGORITHM; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MAJOR CLINICAL STUDY; NEOPLASM; NUCLEOSOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDITY; VIRUS INFECTION;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 67649198801     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.122     Document Type: Article

References (41)

1. Von Mühlen C, Tan E. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-58.
2. Nishimura S, Nishiya K, Hisakawa N, Chikazawa H, Ookubo S, Nakatani K, et al. Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis. Acta Med Okayama 1996;50:261-5.
3. Ravelli A, Felici E, Magni Manzoni S, Pistorio A, Novarinni C, Bozzola E, et al. Patients with antinuclear antibody positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005;52:826-32.
4. Cassani F, Tosti A, Bianchi FB, Fusconi M, Selleri L, Baffoni L, et al. Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies. Clin Exp Rheumatol 1987;5:23-8.
5. Sinico RA, Bollini B, Sabadini E, Di Toma L, Radie A. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. J Nephrol 2002;15(Suppl 6):S20-7.
6. Elkaym O, Burke M, Vardimon N, Zakut V, Yitzhak RB, Paran D, et al. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab. Autoimmunity 2005;38:155-60.
7. Hesselstrand R, Scheia A, Shen GQ, Wiik A, Akesson A. The association of antinuclear antibodies with organ involvement in systemic sclerosis. Rheumatology (Oxford) 2003;42:534-40.
8. Servais G, Daens S, Guillaume MP, Cumps J, Duchateau J, Peretz A. Diagnostic specificities and sensitivities of anti ds DNA, anti membrane DNA and antinucleosomes autoantibodies. Scand J Clin Lab Invest Suppl 2001;235: 61-7.
9. Servais G, Guillaume MP, Dumarey N, Duchateau J. Evidence of autoantibodies to cell membrane associated DNA (cultured lymphocytes): a new specific marker for rapid identification of systemic lupus erythematosus. Ann Rheum Dis 1988;57:606-13.
10. Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S. Presence of nucleosome restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995;38:1485-91.
11. Julkunen H, Salonen EM, Walle TK, Mieetiinen A. Anti-nucleosomes antibodies in the diagnosis of systemic lupus erythematosus. Scand J Rheumatol 2005;34:122-4.
12. Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A, et al. AntiDNA antibodies: a diagnostic and prognostic tool for SLE? Autoimmunity 2005;38:39-45.
13. Nossent HC, Rekvig OP. Is closer linkage between SLE and anti double stranded DNA antibodies a desirable and attainable goal? Arthritis Res Ther 2005;7:85-7.
14. Isenberg D. Anti dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus? Lupus 2004;13:881-5.
15. Gonzalez C, Garcia-Berrocal B, Herraez O, Navajo JA, Gonzalez-Buitrago JM. Anti nucleosomes, anti chromatin, anti dsDNA and anti histones antibody reactivity in systemic lupus erythematosus. Clin Chem Lab Med 2004;42:266-72.
16. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, et al. Antinucleosomes antibodies in SLE: a two-year follow-up study in 101 patients. J Autoimmun 2004;22:235-40.
17. Cortes Hernandez J, Ordi Ros J, Labrador M, Bujan S, Balada E, Segarra A, et al. Antihistone and anti double stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004;116:165-73.
18. Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerrero J. Anti nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford) 2004;43:220-4.
19. Pottel H, Wiik A, Locht H, Gordon T, Roberts-Thompson P, Abraham D, et al. Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA™ ANA Update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol 2004;22:579-88.
20. Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of anti-nuclear antibodies in primary biliary corrhosis. Ann Rheum Dis 1995;54:148-51.
21. Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single stranded and double stranded DNA in anti-nuclear antibody positive type I autoimmune hepatitis. Hepatology 1997;26:567-72.
22. Solans Laque R, Perez Bocanegra C, Salud Salvia A, Fonollosa-Pla V, Rodrigo MJ, Armadans L, et al. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes. Lupus 2004;13:159-64.
23. Papdakiha A, Psyllaki M, Eliopoulos DG, Tsiroyianni A, Eliopoulos GD. Increased frequency and specific reactivity of serum antinuclear antibodies in patients with non-immune chronic idiopathic neutropenia of adults. Acta Haematol 2001;105:13-20.
24. Peng YC, Hsieh SC, Yang DY, Tung CF, Hu WH, Huang WN, et al. Expression and clinical significance of anti-nuclear antibody in hepatitis C virus infection. J Clin Gastroenterol 2001;33:402-6.
25. Peterson SR, Talpur R, Duvic A. Antinuclear antibody seropositivity in patients with cutaneous T cell lymphoma. J Am Acad Dermatol 1998;39:434-8.
26. Imran A, Neelam F, Tariq M. Incidence of circulating anti-nuclear antibodies in cancer patients. Indian J Med Sci 2003;57:113-6.
27. Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of antinuclear antibody titers in "normal" children and adults. J Rheumatol 1999;26:914-9.
28. Yoshida M, Yoshida H, Muso E, Tamura T, Shimada T, Kawai C, et al. Clonotypic comparison of IgG anti-DNA antibodies of healthy subjects and systemic lupus erythematosus patients: studies on heterogeneity and avidity. Immunol Lett 1987;15:139-44.
29. Wanaananukul S, Voramoramethkul W, Kaewopas Y, Hanvivatvong O. Prevalence of positive antinuclear antibodies in healthy children. Asian Pac J Allergy Immunol 2005;23:153-7.
30. Suzuki K, Kawamura M, Mineo M, Shinohara T, Kataharada K, Okada M, et al. The effects of affinity-purified anti-DNA antibodies from patients with systemic lupus erythematosus on the fluorescent antinuclear antibody assay using HEp-2 cells. Clin Chem Lab Med 2002;40: 46-51.
31. Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single-stranded and double stranded DNA in anti-nuclear antibody positive type I autoimmune hepatitis. Hepatology 1997;26:567-72.
32. Krippner H, Merle S, Pirlet K. Enzyme immunoassay for IgG and IgM antibodies against dsDNA and ssDNA. Z Rheumatol 1983;42:256-60.
33. Touloupi E, Routsias JG, Tzioufas AG. Cross-recognition between histones and La/SSB may account for anti DNA reactivity in SLE patients. Clin Exp Immunol 2005;142: 172-9.
34. Kang I, Spierstein R, Quan T, Breittenstein ML. Utility of age, gendre, ANA titer and pattern as predictors of anti ENA and dsDNA antibodies. Clin Rheumatol 2004;23: 50-1.
35. Julkunen H, Salonen EM, Walle TK, Miettinen A. Anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus. Scand J Rheumatol 2005;34: 122-4.
36. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals Arthritis Rheum 1997;40:1601-11.
37. Su Y, Jia RL, Han L, Li ZG. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol 2007;122:115-20.
38. Tonutti E, Blasone N, Visentini D, Poletto M, Villalta D, Tozzoli R, et al. Cell lines that express membrane-associated DNA for anti-DNA antibody detection. Clin Chem Lab Med 2008;46:458-62.
39. Villalta D, Tozzoli R, Bizzaro N, Tonutti E, Ghirardello A, Doria A. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann NY Acad Sci 2005;1050:176-84.
40. Bizzaro N. Autoantibodies as predictor of disease: the clinical and experimental evidence. Autoimmun Rev 2007;6:325-33.
41. Vojdani A. Antibodies as predictors of complex autoimmune diseases. Int J Immunopathol Pharmacol 2008;21: 267-78.